Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sphingosine-1-Phosphate Is a Key Signaling Molecule in Normal Conditions and in Multiple Sclerosis.
Temporal perception, attentional bias, and moral reasoning in multiple sclerosis: a moderated mediation analysis.
Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis.
Outcomes of Cardiovascular Surgery in Patients With Multiple Sclerosis.
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
Galanin receptor 2: A multifunctional modulator in neurological diseases - Structure, mechanisms, and therapeutic prospects.
Sleep Duration Associations with CSF-Tissue Coupling Flexibility and Circadian Synchronization: An Observational Study of Glymphatic-Related Dynamics.
Repurposing Fingolimod as an Antibacterial and Antibiofilm Agent against Carbapenem-Resistant .
Editorial: Host-microbe immunometabolic chat: a new era of organismal communication.
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis.
A Study on the Spectrum of Autonomic Dysfunction in Primary Central Nervous System Demyelinating Disorders in a Tertiary Care Center from Eastern India.
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.
Alteration of adult neural stem cells by gold nanoparticles in a demyelination model induced in the hippocampus of adult male mice: a structural and ultrastructural study.
Roles and therapeutic prospects of the laminin family in disorders of the nervous system.
Early treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis.
Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.
Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
ST8SIA4 and the repair-inflammation axis of lesion remodeling in RRMS.
Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.
Effect of Minocycline on Traumatic Facial Nerve Injury: An Experimental Study.
The Role of Sphingosine-1-Phosphate Signaling in Cerebral Ischemia/Reperfusion Injury and Alzheimer's Disease Pathology.
Inpatient care for people with multiple sclerosis - a secondary data analysis in Germany between 2019 and 2024.
Role of Toll-like receptors and oral-gut-brain axis in neurodegenerative and neuropsychiatric disorders.
Pages
« first
‹ previous
…
1027
1028
1029
1030
1031
1032
1033
1034
1035
…
next ›
last »